UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 55

Sortiert nach

Detection of a Sexually Transmitted Hepatitis C Virus Protease Inhibitor-Resistance Variant in a Human Immunodeficiency Virus–Infected Homosexual Man

Gastroenterology (New York, N.Y. 1943), 2014-09, Vol.147 (3), p.599-601.e1

2014

Volltextzugriff (PDF)

IL28B SNP rs8099917 is strongly associated with pegylated interferon-α and ribavirin therapy treatment failure in HCV/HIV-1 coinfected patients

PloS one, 2010-10, Vol.5 (10), p.e13771

2010

Volltextzugriff (PDF)

Complexity and Catalytic Efficiency of Hepatitis C Virus (HCV) NS3 and NS4A Protease Quasispecies Influence Responsiveness to Treatment with Pegylated Interferon plus Ribavirin in HCV/HIV-Coinfected Patients

Journal of Virology, 2011-06, Vol.85 (12), p.5961-5969

2011

Volltextzugriff (PDF)

IFN-γ response on T-cell based assays in HIV-infected patients for detection of tuberculosis infection

BMC infectious diseases, 2010-12, Vol.10 (1), p.348-348, Article 348

2010

Volltextzugriff (PDF)

Circulating microRNA signatures that predict liver fibrosis progression in patients with HIV-1/hepatitis C virus coinfections

AIDS (London), 2021-07, Vol.35 (9), p.1355-1363

2021

Volltextzugriff (PDF)

Advanced liver fibrosis in HIV/HCV-coinfected patients on antiretroviral therapy

AIDS research and human retroviruses, 2004-12, Vol.20 (12), p.1293-1297

2004

Volltextzugriff (PDF)

IFNL4 ss469415590 variant is a better predictor than rs12979860 of pegylated interferon-alpha/ ribavirin therapy failure in hepatitis C virus/HIV-1 coinfected patients

AIDS (London), 2014-01, Vol.28 (1), p.133-136

2014

Volltextzugriff (PDF)

Single nucleotide polymorphisms in PNPLA3, ADAR-1 and IFIH1 are associated with advanced liver fibrosis in patients co-infected with HIV-1//hepatitis C virus

AIDS (London), 2021-12, Vol.35 (15), p.2497-2502

2021

Volltextzugriff (PDF)

Influence of Hepatitis C Virus Infection on HIV-1 Disease Progression and Response to Highly Active Antiretroviral Therapy

The Journal of infectious diseases, 2005-09, Vol.192 (6), p.992-1002

2005

Volltextzugriff (PDF)

Sustained virological response to interferon plus ribavirin reduces liver‐related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus

Hepatology (Baltimore, Md.), 2009-08, Vol.50 (2), p.407-413

2009

Volltextzugriff (PDF)

Prevalence and factors associated with liver steatosis as measured by transient elastography with controlled attenuation parameter in HIV-infected patients

AIDS (London), 2014-06, Vol.28 (9), p.1279-1287

2014

Volltextzugriff (PDF)

Short-term Treatment With Interferon Alfa Diminishes Expression of HIV-1 and Reduces CD4+T-Cell Activation in Patients Coinfected With HIV and Hepatitis C Virus and Receiving Antiretroviral Therapy

The Journal of infectious diseases, 2016-03, Vol.213 (6), p.1008-1012

2016

Volltextzugriff (PDF)

Applicability of hepatitis C virus kinetics in patients co-infected with HIV

Medicina clínica, 2006-10, Vol.127 (15), p.574-575

Tural i Llàcher, Cristina

2006

Volltextzugriff (PDF)

Association Between Visceral Abdominal Fat Accumulation and Severity of Liver Fibrosis in Nondiabetic Individuals Coinfected by Human Immunodeficiency Virus and Hepatitis C Virus

AIDS research and human retroviruses, 2020-03, Vol.36 (3), p.205

2020

Volltextzugriff (PDF)

Large-scale screening of circulating microRNAs in individuals with HIV-1 mono-infections reveals specific liver damage signatures

Antiviral research, 2018-07, Vol.155, p.106-114

2018

Volltextzugriff (PDF)

Comparison of the Prognostic Value of Liver Biopsy and FIB-4 Index in Patients Coinfected With HIV and Hepatitis C Virus

Clinical infectious diseases, 2015-03, Vol.60 (6), p.950-958

2015

Volltextzugriff (PDF)

Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort Collaboration

Journal of acquired immune deficiency syndromes (1999), 2015-07, Vol.69 (3), p.348

2015

Volltextzugriff (PDF)

HIV/hepatitis C virus-coinfected patients who achieved sustained virological response are still at risk of developing hepatocellular carcinoma

AIDS (London), 2014-01, Vol.28 (1), p.41-47

2014

Volltextzugriff (PDF)

Randomized trial comparing pegylated interferon alpha-2b versus pegylated interferon alpha-2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients

Hepatology (Baltimore, Md.), 2009-01, Vol.49 (1), p.22

2009

Volltextzugriff (PDF)

The natural history of liver cirrhosis in HIV-hepatitis C virus-coinfected patients

AIDS (London), 2011-04, Vol.25 (7), p.899-904

2011

Volltextzugriff (PDF)

Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patients

AIDS (London), 2013-10, Vol.27 (16), p.2541-2549

2013

Volltextzugriff (PDF)

Genetic Variation in IL28B and Treatment-induced Clearance of Hepatitis C Virus in HIV-Positive Patients With Acute and Chronic Hepatitis C

The Journal of infectious diseases, 2011-03, Vol.203 (5), p.595-601

2011

Volltextzugriff (PDF)

The model for end‐stage liver disease score is the best prognostic factor in human immunodeficiency virus 1–infected patients with end‐stage liver disease: A prospective cohort study

Liver transplantation, 2009-09, Vol.15 (9), p.1133-1141

2009

Volltextzugriff (PDF)

Hepatocellular carcinoma in human immunodeficiency virus (HIV)-infected patients: Is it really different, and if so, why?

Journal of hepatology, 2007-10, Vol.47 (4), p.447-450

2007

Volltextzugriff (PDF)

Faldaprevir and pegylated interferon α-2a/ribavirin in individuals co-infected with hepatitis C virus genotype-1 and HIV

AIDS (London), 2015-03, Vol.29 (5), p.571-581

2015

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Aktive Filter

ThemaHiv Infections - Complications

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(55)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(55)
Science & Technology
(45)
Life Sciences & Biomedicine
(44)
Male
(42)
Adult
(41)
Female
(41)
Infectious Diseases
(38)
Middle Aged
(31)
Biological And Medical Sciences
(27)
Hiv Infections - Drug Therapy
(26)
Medical Sciences
(26)
Hepatitis C - Complications
(25)
Virology
(24)
Human Viral Diseases
(23)
Viral Diseases
(23)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(22)
Hepatitis C Virus
(21)
Immunology
(21)
Antiviral Agents - Therapeutic Use
(18)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Detection of a Sexually Transmitted Hepatitis C Virus Protease Inhibitor-Resistance Variant in a Human Immunodeficiency Virus–Infected Homosexual Man

IL28B SNP rs8099917 is strongly associated with pegylated interferon-α and ribavirin therapy treatment failure in HCV/HIV-1 coinfected patients

Complexity and Catalytic Efficiency of Hepatitis C Virus (HCV) NS3 and NS4A Protease Quasispecies Influence Responsiveness to Treatment with Pegylated Interferon plus Ribavirin in HCV/HIV-Coinfected Patients

IFN-γ response on T-cell based assays in HIV-infected patients for detection of tuberculosis infection

Circulating microRNA signatures that predict liver fibrosis progression in patients with HIV-1/hepatitis C virus coinfections

Advanced liver fibrosis in HIV/HCV-coinfected patients on antiretroviral therapy

IFNL4 ss469415590 variant is a better predictor than rs12979860 of pegylated interferon-alpha/ ribavirin therapy failure in hepatitis C virus/HIV-1 coinfected patients

Single nucleotide polymorphisms in PNPLA3, ADAR-1 and IFIH1 are associated with advanced liver fibrosis in patients co-infected with HIV-1//hepatitis C virus

Influence of Hepatitis C Virus Infection on HIV-1 Disease Progression and Response to Highly Active Antiretroviral Therapy

Sustained virological response to interferon plus ribavirin reduces liver‐related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus

Prevalence and factors associated with liver steatosis as measured by transient elastography with controlled attenuation parameter in HIV-infected patients

Short-term Treatment With Interferon Alfa Diminishes Expression of HIV-1 and Reduces CD4+T-Cell Activation in Patients Coinfected With HIV and Hepatitis C Virus and Receiving Antiretroviral Therapy

Applicability of hepatitis C virus kinetics in patients co-infected with HIV

Association Between Visceral Abdominal Fat Accumulation and Severity of Liver Fibrosis in Nondiabetic Individuals Coinfected by Human Immunodeficiency Virus and Hepatitis C Virus

Large-scale screening of circulating microRNAs in individuals with HIV-1 mono-infections reveals specific liver damage signatures

Comparison of the Prognostic Value of Liver Biopsy and FIB-4 Index in Patients Coinfected With HIV and Hepatitis C Virus

Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort Collaboration

HIV/hepatitis C virus-coinfected patients who achieved sustained virological response are still at risk of developing hepatocellular carcinoma

Randomized trial comparing pegylated interferon alpha-2b versus pegylated interferon alpha-2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients

The natural history of liver cirrhosis in HIV-hepatitis C virus-coinfected patients

Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patients

Genetic Variation in IL28B and Treatment-induced Clearance of Hepatitis C Virus in HIV-Positive Patients With Acute and Chronic Hepatitis C

The model for end‐stage liver disease score is the best prognostic factor in human immunodeficiency virus 1–infected patients with end‐stage liver disease: A prospective cohort study

Hepatocellular carcinoma in human immunodeficiency virus (HIV)-infected patients: Is it really different, and if so, why?

Faldaprevir and pegylated interferon α-2a/ribavirin in individuals co-infected with hepatitis C virus genotype-1 and HIV

Aktive Filter

Suchergebnisse filtern